Anticancer activity of ruthenium(II) polypyridine complexes bearing pyrrolidine substituents

Abstract : A set of homoleptic ruthenium polypyridine (bipyridine and terpyridine) complexes flanked with several electron-donating pyrrolidine moieties has been characterized and the anticancer activity was evaluated toward human lung adenocarcinoma epithelial (A549) and murine colon carcinoma (CT26). Good antiproliferative effects were observed with an IC50 ranging from ca. 4 to 21 mu M against both cell lines. Dependence was found between the cytotoxicity, the lipophilicity and the Ru-II/Ru-III oxidation potential. All the studied compounds interacted quite well with albumin while the interaction with DNA was marginal. The biological studies revealed that the ruthenium complexes induced the ROS overproduction which might be one but not the only way of cell death induction.
Type de document :
Article dans une revue
Inorganica Chimica Acta, Elsevier, 2016, 443, pp.86-90. 〈10.1016/j.ica.2015.12.021〉
Domaine :
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01496645
Contributeur : Srsmc Ul <>
Soumis le : lundi 27 mars 2017 - 16:47:31
Dernière modification le : vendredi 15 juin 2018 - 16:02:03

Identifiants

Collections

Citation

Olga Mazuryk, Michal Lomzik, David Martineau, Marc Beley, Malgorzata Brindell, et al.. Anticancer activity of ruthenium(II) polypyridine complexes bearing pyrrolidine substituents. Inorganica Chimica Acta, Elsevier, 2016, 443, pp.86-90. 〈10.1016/j.ica.2015.12.021〉. 〈hal-01496645〉

Partager

Métriques

Consultations de la notice

49